PapersPMID:30699971
Blueberries Improve Pain, Gait Performance, and Inflammation in Individuals with Symptomatic Knee Osteoarthritis.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- RCT
No finding here moved its endpoint.
What did not
How to read these marks →“There was no difference between the blueberry and placebo group in pain, stiffness, and difficulty to perform daily activities at any time point of the study.”
- Dose studied
- 40 g/day as two 20 g packets reconstituted in 10-12 ounces of water, for 4 months, versus 40 g/day maltodextrin placebo powder
- Population
- Adults aged 45 to 79 with symptomatic knee osteoarthritis; between-group comparison at every time point (baseline, 2 months, 4 months)
- Dose studied
- 40 g/day as two 20 g packets reconstituted in 10-12 ounces of water, for 4 months, versus 40 g/day maltodextrin placebo powder
- Population
- Adults aged 45 to 79 with symptomatic knee osteoarthritis; between-group comparison at every time point (baseline, 2 months, 4 months)
“Besides the baseline differences in systolic blood pressure, there was no significant difference between the blueberry and the placebo group in regard to weight, height, BMI, or systolic and diastolic blood pressure, at any time point.”
- Dose studied
- 40 g/day for 4 months versus 40 g/day maltodextrin placebo powder
- Population
- Adults aged 45 to 79 with symptomatic knee osteoarthritis; between-group comparison at every time point
- No detected effect on body mass
moderate
- Dose studied
- 40 g/day for 4 months versus 40 g/day maltodextrin placebo powder
- Population
- Adults aged 45 to 79 with symptomatic knee osteoarthritis; between-group comparison at every time point
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Men and women aged 45 to 79 with self-reported symptomatic knee osteoarthritis; freeze-dried whole blueberry powder from the US Highbush Blueberry Council; species not further stated
- Participants
- 63
- Comparator
- placebo
- Duration
- 122 days
- Endpoints measured
- 40